Adverse Drug Reaction News Bulletins
ADR News Bulletin 2017 May (Volume 19 Number 1)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
1 May 2017
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
New recommendations on the use of domperidone
Risk of hepatitis B virus reactivation with direct-acting antivirals
Analysis of adverse event (AE) reports for the year 2016
Highlights of local safety signals for the year 2016
List of Dear Healthcare Professional Letters on safety concerns
Risk of falsely elevated oestradiol levels due to cross-reactivity of fulvestrant with oestradiol immunoassays
Click on the link below to download the issue in pdf: